Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for prevention of zoledronic acid acute phase response
ACTRN12615000794505Phase 4Completed
- Sponsor
- Bone & Joint Research Group
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoporosis, Paget's disease of bone and Metabolic osteopathies comparing Dexamethasone + zoledronic acid with Placebo + zoledronic acid (2 arms). Primary endpoint: Between-group difference in temperature change from baseline. Started Sep 2015; status: completed.
02
Drugs
dexamethasone
03
Conditions
osteoporosisPaget's disease of boneMetabolic osteopathies
Beyond the preview
Go deeper on ACTRN12615000794505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000794505.